PUBLICATIONS

Books Published

1.      P.V.G.K. Sarma “Molecular Biology A Practical Manual” (2017) MJP publishers. ISBN No. 978-81-8094-340-9.

2.      Swathi Somisetty, P. Santhosh Kumar and P.V.G.K. Sarma (2017) Role of ANN Techniques in Detection of Breast Cancer. Lambert Academic publishing. ISBN No. 978-3-330-34470-9.

3.      Nanda Kumar Yellapu, Sarma PVGK and Bhaskar Matcha (2017) Structure and functional correlations of  Human glucokinase, Lambert Academic publishing. ISBN: 978-3-659-63553-3.

Book Chapter Published

4.      Sarma PVGK and Sivakumar V (2010) “The Diagonsis of Autosomal Dominant Polycystic Kidney Disease”. Chapter written in the book Polycystic Kidney Disease, edited by K.V. Dakshinamurthy, ECAB clinical update Nepherology.  ELESEVIER publications.

Research Papers published

1.      Sarma PV, Sarma PU, Murthy PS. Isolation, purification and characterization of intracellular calmodulin like protein (CALP) from Mycobacterium phlei. FEMS Microbiol Lett. 1998;1;159(1):27-34. [impact factor 2016 1.765]

2.      Kumar A, Kumar S, Sarma PV, Sharma AK. Differential Conformational Environment of Tryptophan in Epsilon Native Prototoxin and Active Toxin FromClostridium PerfringensType D. J BiochemMolBiolBiophys. 2002;6(2):147-150.

3.      Manjunath M, Sarma PVGK, Reddy OVS. In vitro Evaluation of antibacterial activity of Actiniopterisradiata (Sw.)Link. Journal of pharmacy and chemistry. 2008;2(2):112-118.

4.      Sarma PVGK, Hari Prasad O, Prasad UV, Manohar Reddy M, Kumar Swamy Reddy K, Subramanyam G. Purification and characterization of Human Intestinal alkaline phosphatase and its role in the colonization of Helicobacter pylori in the duodenum. Current Trends in Biotechnology and Pharmacy. 2009;3(4):390-396.

5.      Himakar Reddy K, BalaNagi Reddy K, Sarma PVGK, Reddy OVS. In vitro Studies on Antimicrobial and Antioxidant Activities of Dilleniaindica Seed Extract. Journal of Pure and Applied Microbiology. 2009;3(2):769-776.

6.      Hariprasad O, Gopinath VP, Navya A, Yugandhar VG, Sarma PVGK. Particulate vaccine for bacterial diseases. International Journal of Drug Discovery. 2010;2(2):17-19.

7.      O. Hari Prasad, V. Nagarjuna, Ch. Lakshmi Prasanna, D. Vasu, VG.Yugandhar, U. Venkateswar Prasad, PVLN Srinivas Rao, Abhijit Chaudhary, OVS Reddy, PVGK Sarma. UV light Induces Transposition of blaZ gene resulting in high expression of β-lactamase in a clinical isolate of Staphylococcus aureus sensitive to amipicillin. Journal of pure and Applied Microbiology. 2010;4(2):609-616.

8.      O. Hari Prasad, A. Navya, D. Vasu, T. Chiranjeevi, M. Bhaskar, K.V. SreedharBabu, P.V.G.K. Sarma. Protective effects of Prosopisjuliflora against Staphylococcus aureus induced hepatotoxicity in rats. Int J Pharm Biomed Res 2011;2(3):172-178.

9.      Hari Prasad O, Nanda Kumar Y, Reddy OV, Chaudhary A, Sarma PV. Cloning, expression, purification and characterization of UMP kinase from Staphylococcus aureus. Protein J. 2012;31(4):345-52. [impact factor 2016 1.139]

10.  RathnakarReddi KVN, Santhosh Kumar P, Venkateswara Prasad U, Yeswanth S, Swarupa V, Vasu D, Venkatesh K, Srikanth L, Nanda Kumar Y, Sarma PVGK. Isolation, purification and characterization of glucokinase from Staphylococcus aureus. Journal of pharmacy research 2013;6:205-209.

11.  Venkatesh K, Reiner G, Debral AK, Kirpan P, Reers M, Murthy PVVS, Swarupa V, Srikanth L, Sarma PVGK. “pH Optimization and Production of High Potent Cellular Vaccine by Bordetella pertussis”. International Journal of Biotechnology and Bioengineering Research 2012;3(1):17-25.

12.  Venkatesh K, Srikanth L, Swarupa V, Yeswanth S, Prasad UV, Vasu D, Vishnuvardhan GP, Srinivas P, Santhoshkumar P, Sowjenya G, Nandakumar Y, Chaudhary A, Sarma PVGK. Isolation, purification and characterization of pyruvate kinase from Staphylococcus aureus: a potential drug target. J ClinSci Res 2012;1:76-82.

13.  Prasad UV, Vasu D, Kumar YN, Kumar PS, Yeswanth S, Swarupa V, Phaneendra BV, Chaudhary A, Sarma PV. Cloning, Expression and Characterization of NADP-Dependent Isocitrate Dehydrogenase from Staphylococcus aureus. ApplBiochemBiotechnol. 2013;169(3):862-9.  [impact factor 2016 1.751]

14.  Lakshmi HP, Prasad UV, Yeswanth S, Swarupa V, Prasad OH, Narasu ML, Sarma PV. Molecular characterization of α-amylase from Staphylococcus aureus. Bioinformation. 2013;9(6):281-5. [impact factor 2016 0.8]

15.  Swarupa V, Yeswanth S, Prasad UV, Vasu D, Venkatesh K, Srikanth L, Anitha P, Manasa C, Santhosh Kumar P, Sowjenya G, Nandakumar Y, Chaudhary A, PVGK Sarma. Characterization of succinate dehydrogenase flavoprotein from Staphylococcus aureus ATCC 12600. J ClinSci Res 2013;2:81-87.

16.  Lakshmi HP, Yeswanth S, Prasad UV, Vasu D, Swarupa V, Kumar PS, Narasu ML, Sarma PVGK. Cloning, expression and characterization of glucokinase gene involved in the glucose-6- phosphate formation in Staphylococcus aureus. Bioinformation. 2013;9(4):169-173. [impact factor 2016 0.8]

17.  Hari Prasad O, Nanda Kumar Y, Santhosh Kumar P, Reddy OVS, Chaudhary A, PVGK Sarma. Staphylococcus aureus TMPK and TK showing distinct structural differences with human TMPK and TK:A probable explanation in the pathogenesis. Journal of pharmacy research. 2013;7(1):1-7.

18.  Kishore KA, Hari Prasad O, Sudheer A, Mohan K, Vinay C, Chiranjeevi P, Bhaskar M, Sarma PVGK, Papa Rao A, Reddy R. Identification of predominant subgingival microbes in acute myocardial infarction patients of South Indian population. Journal of Indian college of cardiology, 2013;3:104-110.

19.  Yeswanth S, Kumar YN, Prasad UV, Swarupa V, Koteswara Rao V, Sarma PVGK. Cloning and Characterization of L - Lactate dehydrogenase gene of Staphylococcus aureus, Anaerobe 2013;24:43-48. [impact factor 2016 2.278]

20.  Yeswanth S, Lalith Kumar CH, Swarupa V, Prasad U.V,Vasu D, Nanda Kumar Y, Srikanth L, Venkatesh K, Sowjenya G, Santhosh kumar P, Kavya D, Chaudhary A, Sarma PVGK. Characterization of Inosine Monophosphate Dehydrogenase from Staphylococcus aureus ATCC12600 and its involvement in biofilm formation, J ClinSci Res 2013;2:203-210.

21.  Swarupa V, Sundari R, Prasad UV, Yeswanth S, Sarma PVGK. Induced mutagenesis in Staphylococcus aureus ATCC 12600 resulting over expression of Streptomycin 3''-adenylyltransferase1, Journal of Pure and Applied Microbiology. 2013; 7(3) 2417-2422.

22.  PVGK Sarma, L.Srikanth, K. Venkatesh, P.S.N.Murthy, P.Usha Sarma. Isolation, purification and characterization of cardiolipin synthase from Mycobacterium phlei. Bioinformation.2013; 9(13): 690-695. [Impact factor0.8]

23.  Kumar PS, Kumar YN, Prasad UV , Yeswanth S, Swarupa V, Sowjenya G, Venkatesh K, Srikanth L, Rao VK, Sarma PVGK. In silico designing and molecular docking of a potent analog against Staphylococcus aureus porphobilinogen synthase. Journal of Pharmacy and Bioallied Sciences July-September 2014; 6 (3), 158-166

24.  Prasad UV, Swarupa V, Yeswanth S, Kumar PS, Kumar ES, Reddy KMK, Kumar YN, Jhansi Rani V, Chaudhary A, Sarma PVGK. Structural and Functional analysis of Staphylococcus aureus NADP-dependent IDH and its comparison with Bacterial and Human NADP dependent IDH. Bioinformation 2014;10(2):081-086.[impact factor 2016 0.8]

25.  Kumar PS, Kumar YN, Prasad UV , Yeswanth S, Swarupa V, Venkatesh K, Srikanth L, Rao VK, Sarma PVGK. Comparative Structural and Functional Analysis of Staphylococcus aureus Glucokinase with other Bacterial Glucokinases. Indian Journal of Pharmaceutical Sciences. 2014; 76(5):430-436.[Impact Factor 0.66]

26.  Swarupa V, Sundari RA, Prasad UV, Yeswanth S, Prasad OH, Sarma PVGK. Identification of methicillin resistant Staphylococcus aureus in raw cow milk through amplification of mecA. Journal of Pure and Applied Microbiology. 2014; 8(6) 4909-4915.

27.  Chiranjeevi T, Hari Prasad O, Prasad UV, Kumar AK, Praveen Chakravarthi V, Balaji Rao P, Sarma PVGK, Reddy N, Reddy R, Bhaskar M. Identification of Microbial Pathogens in Periodontal disease and Diabetic patients of South Indian Population. Bioinformation 2014;10(4): 241-244.[Impact factor 0.8]

28.  Prasad UV, Vasu D, Yeswanth S, Swarupa V, Sunitha MM, Choudharry A, Sarma PVGK. Phosphorylation controls the functioning of Staphylococcus aureusIsocitrate dehydrogenase - favours biofilm formation. Journal of Enzyme Inhibition and Medicinal Chemistry. 2015;30(4):655-661. [impact factor 4.293]

29.  Vasu D, Sunitha MM, Srikanth L, Swarupa V, Prasad UV, Sireesha K, Yeswanth S, Kumar PS, Venkatesh K, Chaudhary A, Sarma PVGK. In Staphylococcus aureus the regulation of Pyruvate kinase activity by serine/threonine protein kinase favors biofilm formation. 3 Biotech. 2015; 5:505–512. [impact factor 1.361]

30.  Prasad UV, Vasu D, Gowtham RR, Pradeep CK, Swarupa V, Yeswanth S, Choudhary A, Sarma PVGK. Cloning, expression and characterization of NAD Kinase from Staphylococcus aureus involved in the formation of NADP (H)- a key molecule in the maintaining of redox status and biofilm formation. Adv Biomed Res. 2017;6:97. doi: 10.4103/2277-9175.211833.

31.  Swarupa V, Chaudhury A, Krishna Sarma PV. Effect of 4-methoxy 1-methyl 2-oxopyridine 3-carbamide on Staphylococcus aureus by inhibiting UDP-MurNAc-pentapeptide, peptidyl deformylase and uridine monophosphate kinase. J ApplMicrobiol. 2017;122(3):663-675.[Impact factor 2.099]

32.  Vasu D, Santhosh Kumar P, Venkateswara Prasad U, Swarupa V, Yeswanth S, Srikanth L, Sunitha MM,  Choudhary A, Sarma PV. In Staphylococcus aureus protein tyrosine kinase phosphorylation effects the functioning of glucokinase and biofilm formation. Iran Biomed J. 2017;21(2):94-105.

33.  Vasu D, Santhosh Kumar P, Kumar YN, Chakravarthi VP, Sarma PVGK. Structural and Functional Analysis of Serine/Threonine Protein Kinase of Staphylococcus aureus Exhibiting Variations with Other Bacterial PknB. J Anal Pharm Res. 2016;3(7):00081. DOI: 10.15406/japlr.2016.03.00081.

34.  Yeswanth S and Sarma PVGK. Proteins are the Major Players in the Formation of Staphylococcus aureus Biofilms. J Anal Pharm Res 2017; 4(2): 00097.

35.  Yeswanth S, Chaudhury A, Sarma PVGK. Quantitative expression analysis of SpA, FnbA and Rsp genes in Staphylococcus aureus - Actively associated in the formation of biofilms.CurrMicrobiol. 2017 Aug 18. doi: 10.1007/s00284-017-1331-x[impact factor 2016 1.322]

36.  Sarma PV, Purkayastha S, Madan T, Sarma PU. Expression of an epitopic region of AspfI, an allergen/antigen/cytotoxin of Aspergillus fumigatus. Immunol Lett. 1999;70(3):151-5. [impact factor 2016 2.860]

37.  Sarma PU, Sarma PV, Madan T. Challenges in prevention, diagnosis and therapy of emerging fungal diseases. Aspergillosis: A case study. Indian J ClinBiochem. 2000;15(Suppl 1):43-50.

38.  Nigam S, Sarma PVGK, Ghosh PC, Sarma PU. Characterization of Aspergillus fumigatus protein disulfide isomerase family gene. Gene. 2001;281(1-2):143-50. [impact factor 2.415]

39.  Reddy KH, Sharma PV, Reddy OV. A comparative in vitro study on antifungal and antioxidant activities of Nerviliaaragoanaand Atlantiamonophylla. Pharm Biol. 2010;48(5):595-602.[impact factor 1.916]

40.  K. Himakar Reddy, Patrick Govender, O. V. S. Reddy, P.V. G. K. Sarma. Effect of hexane extract of Dilleniaindica seed on the activity of secreted aspartyl proteinase of Candida albicans and its kinetic studies. Journal of Medicinal Plants Research. 2012;6(44),5599-5603.

41.  Himakar Reddy Kandappa, Karen Pillay, VijayaSarathi Reddy Obulam, Sarma PVGK and Patrick Govender.  In vitro Antifungal, Antioxidant and Cytotoxic Activities of a Partially Purified Protein Fraction from Atlantiamonophylla Linn (Rutaceae) Leaf. Tropical Journal of Pharmaceutical Research. 2015;14 (3):487-493.

42.  Himakar Reddy K, Tharanath V, Nagi Reddy KB, Sarma PVGK, Reddy OVS. Studies on hepatoprotective effect of hexane extract of Dilleniaindica against CCl 4 induced toxicity and its safety evaluation in wistar albino rats. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010;1(3):441–450.

43.  Santhosh Kumar P, Srinivasa Rao V, Abdul K, Prasad UV, Nanda kumar Y, Sarma PVGK. Validation, quantitative and qualitative analysis of felodipine drug using HPLC. Journal of Pharmacy Research. 2012;5(4):1838-1840.

44.  Santhosh Kumar P, Jayanthi B, Abdul K, Prasad UV, Nanda Kumar Y, PVGK Sarma. A Validated High performance liquid chromatography (HPLC) Method for the Estimation of Cefuroxime axetil. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2012;3(3): 223-228.

45.  Naresh VVS, Reddy ALK, Sivaramakrishna G, Sarma PVGK, Vardhan RV, Siva Kumar V. Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy. Indian Journal of Nephrology. 2009;19(4):145-148.

46.  Naresh VV, Reddy AL, Sivaramakrishna G, Sarma PV, Vardhan RV, Kumar VS. Angiotensin converting enzyme gene polymorphism in type 2 diabetics with nephropathy. Indian J Nephrol. 2010;20(2):119.

47.  Kumar YN, Kumar PS, Sowjenya G, Rao VK, Yeswanth S, Prasad UV, Pradeepkiran JA, Sarma PV, Bhaskar M. Comparison and correlation of binding mode of ATP in the kinase domains of Hexokinase family. Bioinformation. 2012;8(12):543-547.[impact factor 0.8]

48.  Himabindu G, Rajasekhar D, Latheef K, Sarma PV, Vanajakshamma V, Chaudhury A, Bitla AR. Factor V Leiden mutation is not a predisposing factor for acute coronary syndromes. Indian Heart J. 2012;64(6):570-575.

49.  Siddhartha Kumar B, Sarma PV, Lava Kumar Reddy, B. ManojPrajwal, Alladi Mohan and V. Siva Kumar. Mutation analysis of PKD1 gene in Indian population. Saudi J.Kidney.Dis. Transpl 2012;23(1), 143-147. 

50.  Nanda Kumar Y, Kalpana K, Venkateswara Swamy K, Sarma PVGK, M. Bhaskar. Molecular dynamics simulations of MODY 2 mutated Glucokinase structures revealed significant conformational variations explaining reasons for hyperglycemic condition. Int J Pharm Bio Sci, 2012;3(4):493–499.

51.  Srikanth L, Ramaiah J, Venkatesh K, Sriram P, Tejachandra G, Kannan T, Sarma PVGK. Differential Expression of ADH and ALDH2 can be a Diagnostic Marker in Gastroesophageal Cancer. Current Trends in Biotechnology and Pharmacy 2012;6(1):112-118.

52.  Swathi S, Rizwana S, AnjanBabu G, Santhosh Kumar P, Sarma PVGK. Classification of Neural network structures for Breast cancer diagnosis. International Journal of Computer Science and Communication, 2012;3(1):227-231.

53.  Nanda Kumar Y, Pradeep Kiran JA, Santhosh Kumar P, Yeswanth S, Kalpana K, Koteswara Rao V, Sarma PVGK, Bhaskar M. Molecular docking assessment of pyridone derivatives as glucokinase activators. J ClinSci Res 2012;1:163-173.

54.  Yellapu NK, Kandlapalli K, Valasani KR, Sarma PV, Matcha B Structural Variations of Human Glucokinase Glu256Lys in MODY2 Condition Using Molecular Dynamics Study. Biotechnol Res Int. 2013;2013:264793.

55.  Kumar PS, Venkatesh K, Srikanth L, Sarma PVGK, Reddy AR, Subramanian S, Phaneendra BV. Novel three missense mutations observed in Von  Hippel-Lindau gene in a patient reported with renal cell carcinoma; Indian Journal of Human Genetics. 2013;19(3): 373-376.

56.  Yellapu N, Mahto MK, Valasani KR, Sarma PVGK, Matcha B. Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding - explains hyperglycemia in type 2 diabetic patients. J BiomolStructDyn. 2014;15:1-14.[impact factor 3.123]

57.  Kumar YN, Rao VK, Kumar PS, Sowjenya G, Sarma PVGK, Bhaskar M. Identification and analysis of novel R308K mutation in Glucokinase of type2 diabetic patient and its kinetic correlation. Biotechnology and Applied Biochemistry. 2014;61(5):572-581. [impact factor 1.413]

58.  Kumar YN, Navya A, Kalpana K, RavendraBabu K, Jhansi Rani V, Hariprasad O, Nagaraju C, Sarma PVGK, Bhaskar M. Design, synthesis, in silico, and in vitro evaluation of novel pyrimidine phosphonates with cytotoxicity against breast cancer cells. Med Chem Res 2014; 23: 317-328. [impact factor 2016 1.277]

59.  Kumar PS, Venkatesh K, Srikanth L, Prasad UV, SyamaSundar T, Ram Prasad Reddy A, Tyagi A, Radhika K, Sarma PVGK. Novel frame shift mutations (‘A’ deletion) observed in exon 9 ofWilms' tumor (WT1) gene in a patient reported with glomerulosclerosis. Gene 2014;546: 63–67. [impact factor 2.415]

60.  Kumar PS, Venkatesh K, Sowjenya G, Srikanth L, Sunitha MM, Prasad UV, Swarupa V, Yeswanth S, Naveen PS, Sridhar A, Kumar VS, Sarma PV. Mutations in exons 3 and 7 resulting in truncated expression of human ATP6V1B1 gene showing structural variations contributing to poor substrate binding- causative reason for distal renal tubular acidosis with sensorineural deafness. J BiomolStructDyn. 2015;33(10):2094-103.[impact factor 2016 3.123]

61.  Naveen PS, Srikanth L, Venkatesh K, Sarma PV, Sridhar N, Krishnakishore C, Sandeep Y, Manjusha Y, Sivakumar V. Distal Renal Tubular Acidosis with Nerve Deafness Secondary to ATP6B1 Gene Mutation. Saudi J Kidney Dis Transpl.  2015; 26(1):119-121.

62.  Swathi S, Santhosh Kumar P, Sarma PVGK. Approach of Jordan Elman Neural Network to Diagnose Breast Cancer on Three Different Data Sets. International Journal of Advanced Research in Computer and Communication Engineering. 2015; 4(11): 321-325.

63.  Verma A, Jothibai S, Sarma PVGK, Nagaraj M, Srikant L, Vasavi B, Chandramouli P, Kalawat U. Prevalence of hepatitis C virus infection and its genotypes among the blood donors at Tirupati, Andhra Pradesh. J ClinSci Res 2015;4:266-272.

64.  Kumar BS, Kumar PS, Sowgandhi N, Prajwal BM, Mohan A, Sarma KV, Sarma PV. Identification of novel mutations in CD2BP1 gene in clinically proven rheumatoid arthritis patients of south India. European Journal of Medical Genetics. 2016; 59: 404-412.[impact factor 2.137]

65.  Yellapu NK, Kilaru RB, Chamarthi N, Sarma PVGK, Matcha B. Structure based design, synthesis and biological evaluation of amino phosphonate derivatives as human glucokinase activators. ComputBiol Chem. 2017;68:118-130. [impact factor 1.331]

66.  Babu PP, Kumar PS, Mohan A, Kumar BS, Sarma PVGK.Novel mutations in the exon 5, intron 2 and 3' UTR regions of IL-12B gene were observed in clinically proven tuberculosis patients of south India.Cytokine. 2017;99:50-58. [impact factor 3.488]

67.  Harsha EV, Rajashekar D, Vanaja V, Sarma PV, Sridhar K, Madhavi R, Kapil C. Evaluation of On-Clopidogrel platelet reactivity overtime, SYNTAX SCORE, genetic polymorphisms and their relationship to one year clinical outcomes in STEMI patients undergoing PCI. Minerva Cardioangiol. 2018;66(1):16-25.[impact factor 0.695]

68.  Sarma PVGK, Subramanyam G. In vitro cardiogenesis can be initiated in human CD34+ cells. Indian Heart J. 2008;60(2):95-100. 

69.  Venkatesh K, Srikanth L, Vengamma B, Chandrasekhar C, Sanjeevkumar A, Mouleshwara Prasad BC, Sarma PVGK. In vitro differentiation of cultured human CD34+ cells into astrocytes. Neurol India 2013;61:383-388.[impact factor 1.758]

70.  Venkatesh K, Srikanth L, Vengamma B, Chandrasekhar C, Mouleshwara Prasad BC, Sarma PVGK. In vitro transdifferentiation of Human cultured CD34+ stem cells into Oligodendrocyte precursors using Thyroid hormones. Neuroscience Letters. 2015; 588:36-41.[impact factor 2.180]

71.  Srikanth L, Sunitha MM, Venkatesh K, Kumar PS, Chandrasekhar C, Vengamma B, Sarma PV. Anaerobic Glycolysis and HIF1α Expression in Haematopoietic Stem Cells Explains Its Quiescence Nature. J Stem cells. 2015;10 (2):97-106.

72.  Srikanth L, VenkateshK, Sunitha MM, Kumar PS, Chandrasekhar C, Vengamma B, Sarma PV. In vitro generation of Type II pneumocytes can be initiated in human CD34+ stem cells. Biotechnology Letters. 2016;38:237–242. [impact factor 1.730]

73.  Sunitha MM, Srikanth L, Santhosh Kumar P, Chandrasekhar C, Sarma PV. In vitro differentiation potential of human hematopoietic CD34+cells towards pancreatic βcells.Cell Biol Int. 2016;40(10):1084-93.[impact factor 1.831]

74.  Srikanth L, Sunitha MM, Kumar PS, Chandrasekhar C, Vengamma B, Sarma PV. Gel based in vitro 3D model exploring the Osteocytic potentiality of human CD34+ stem cells. MolBiol Rep. 2016;43(11):1233-1242.[impact factor 1.828]

75.  Sunitha MM, Srikanth L, Santhosh Kumar P, Chandrasekhar C, Sarma PV. Role of STPK in maintaining the quiescent nature of human CD34 + stem cells. Journal of Stem Cells. 20016; 11(3):125-133.

76.  Kotakadi VS, Gaddam SA, Venkata SK, Sarma PV, Sai Gopal DV.Biofabrication and spectral characterization of silver nanoparticles and their cytotoxic studies on human CD34 +ve stem cells. 3 Biotech. 2016 Dec;6(2):216.[impact factor 1.361]

77.  Santhosh Kumar P, Chandrasekhar C, Srikanth L, Sunitha MM, Sarma PV. In vitro differentiation and characterization of Human hematopoietic CD34+ stem cells into Erythrocytes. J Stem Cells. 2017;12(2):63-70.

78.  Chandrasekhar C, Kumar PS, Kumar MS, Sarma PVGK. A Retrospective Study of JAK-2 Mutations, Endogenous Erythroid Colony Formation Assay in Absolute Erythrocytosis Patients in a Tertiary Care Centre, South India. J Stem Cells. 2017;12(2):71-79.

79.  Sunitha MM, Srikanth L, Santhosh Kumar P, Chandrasekhar C, Sarma PV. Down regulation of PAX2 promotes in vitro differentiation of podocytes from human CD34+ cells. Cell Tissue Res. 2017;370(3):477-488.[impact factor 2.787]